vs

Side-by-side financial comparison of Dexcom (DXCM) and GRIFFON CORP (GFF). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $649.1M, roughly 1.9× GRIFFON CORP). Dexcom runs the higher net margin — 21.2% vs 9.9%, a 11.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -1.8%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Griffon Corporation is a multinational conglomerate headquartered in New York City. It operates as a diversified management and holding company. The company has four subsidiaries: Ames True Temper, ClosetMaid, Clopay Building Products, and CornellCookson. Griffon has been publicly traded since 1961 and is listed on the New York Stock Exchange as a component stock of the S&P SmallCap 600, S&P Composite 1500, and Russell 2000 indices.

DXCM vs GFF — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.9× larger
DXCM
$1.3B
$649.1M
GFF
Growing faster (revenue YoY)
DXCM
DXCM
+18.9% gap
DXCM
21.6%
2.6%
GFF
Higher net margin
DXCM
DXCM
11.3% more per $
DXCM
21.2%
9.9%
GFF
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-1.8%
GFF

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
GFF
GFF
Revenue
$1.3B
$649.1M
Net Profit
$267.3M
$64.4M
Gross Margin
62.9%
41.1%
Operating Margin
25.6%
17.5%
Net Margin
21.2%
9.9%
Revenue YoY
21.6%
2.6%
Net Profit YoY
153.6%
-9.1%
EPS (diluted)
$0.67
$1.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
GFF
GFF
Q1 26
$1.3B
Q4 25
$1.3B
$649.1M
Q3 25
$1.2B
$662.2M
Q2 25
$1.2B
$613.6M
Q1 25
$1.0B
$611.7M
Q4 24
$1.1B
$632.4M
Q3 24
$994.2M
$659.7M
Q2 24
$1.0B
$647.8M
Net Profit
DXCM
DXCM
GFF
GFF
Q1 26
$267.3M
Q4 25
$267.3M
$64.4M
Q3 25
$283.8M
$43.6M
Q2 25
$179.8M
$-120.1M
Q1 25
$105.4M
$56.8M
Q4 24
$151.7M
$70.9M
Q3 24
$134.6M
$62.5M
Q2 24
$143.5M
$41.1M
Gross Margin
DXCM
DXCM
GFF
GFF
Q1 26
62.9%
Q4 25
62.9%
41.1%
Q3 25
60.5%
41.7%
Q2 25
59.5%
43.2%
Q1 25
56.9%
41.2%
Q4 24
58.9%
41.8%
Q3 24
59.7%
39.9%
Q2 24
62.4%
38.5%
Operating Margin
DXCM
DXCM
GFF
GFF
Q1 26
25.6%
Q4 25
25.6%
17.5%
Q3 25
20.1%
18.0%
Q2 25
18.4%
-20.5%
Q1 25
12.9%
16.5%
Q4 24
17.0%
17.7%
Q3 24
15.3%
16.9%
Q2 24
15.7%
13.8%
Net Margin
DXCM
DXCM
GFF
GFF
Q1 26
21.2%
Q4 25
21.2%
9.9%
Q3 25
23.5%
6.6%
Q2 25
15.5%
-19.6%
Q1 25
10.2%
9.3%
Q4 24
13.6%
11.2%
Q3 24
13.5%
9.5%
Q2 24
14.3%
6.3%
EPS (diluted)
DXCM
DXCM
GFF
GFF
Q1 26
$0.67
Q4 25
$0.67
$1.41
Q3 25
$0.70
$1.04
Q2 25
$0.45
$-2.65
Q1 25
$0.27
$1.21
Q4 24
$0.37
$1.49
Q3 24
$0.34
$1.29
Q2 24
$0.35
$0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
GFF
GFF
Cash + ST InvestmentsLiquidity on hand
$917.7M
$95.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$108.9M
Total Assets
$6.3B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
GFF
GFF
Q1 26
$917.7M
Q4 25
$917.7M
$95.3M
Q3 25
$1.8B
$99.0M
Q2 25
$1.2B
$107.3M
Q1 25
$904.9M
$127.8M
Q4 24
$606.1M
$152.0M
Q3 24
$621.2M
$114.4M
Q2 24
$939.2M
$133.5M
Total Debt
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
Q3 25
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Stockholders' Equity
DXCM
DXCM
GFF
GFF
Q1 26
$2.7B
Q4 25
$2.7B
$108.9M
Q3 25
$2.7B
$74.0M
Q2 25
$2.6B
$63.9M
Q1 25
$2.3B
$214.7M
Q4 24
$2.1B
$227.8M
Q3 24
$2.0B
$224.9M
Q2 24
$2.4B
$223.5M
Total Assets
DXCM
DXCM
GFF
GFF
Q1 26
$6.3B
Q4 25
$6.3B
$2.1B
Q3 25
$7.5B
$2.1B
Q2 25
$7.3B
$2.1B
Q1 25
$6.8B
$2.3B
Q4 24
$6.5B
$2.3B
Q3 24
$6.4B
$2.4B
Q2 24
$6.8B
$2.4B
Debt / Equity
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
Q3 25
Q2 25
22.71×
Q1 25
7.16×
Q4 24
6.48×
Q3 24
6.78×
Q2 24
6.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
GFF
GFF
Operating Cash FlowLast quarter
$107.0M
Free Cash FlowOCF − Capex
$99.3M
FCF MarginFCF / Revenue
15.3%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.66×
TTM Free Cash FlowTrailing 4 quarters
$278.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
$294.0M
$107.0M
Q3 25
$659.9M
$75.0M
Q2 25
$303.0M
$123.1M
Q1 25
$183.8M
$16.5M
Q4 24
$301.4M
$142.9M
Q3 24
$199.5M
$72.1M
Q2 24
$279.4M
$122.1M
Free Cash Flow
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
$192.1M
$99.3M
Q3 25
$579.4M
$62.4M
Q2 25
$208.9M
$114.4M
Q1 25
$96.8M
$2.8M
Q4 24
$176.8M
$125.5M
Q3 24
$88.3M
$51.6M
Q2 24
$213.3M
$107.5M
FCF Margin
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
15.3%
15.3%
Q3 25
47.9%
9.4%
Q2 25
18.1%
18.6%
Q1 25
9.3%
0.5%
Q4 24
15.9%
19.8%
Q3 24
8.9%
7.8%
Q2 24
21.2%
16.6%
Capex Intensity
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
8.1%
1.2%
Q3 25
6.7%
1.9%
Q2 25
8.1%
1.4%
Q1 25
8.4%
2.2%
Q4 24
11.2%
2.8%
Q3 24
11.2%
3.1%
Q2 24
6.6%
2.2%
Cash Conversion
DXCM
DXCM
GFF
GFF
Q1 26
Q4 25
1.10×
1.66×
Q3 25
2.33×
1.72×
Q2 25
1.69×
Q1 25
1.74×
0.29×
Q4 24
1.99×
2.02×
Q3 24
1.48×
1.15×
Q2 24
1.95×
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

GFF
GFF

Consumer And Professional Products$241.1M37%
Residential Repairand Remodel$202.1M31%
International Excluding North America$97.8M15%
Retail$47.3M7%
Residential New Construction$32.5M5%
Other$14.2M2%
Industrial$14.1M2%

Related Comparisons